CROI 2015 Program and Abstracts

Poster Listings

TUESDAY, FEBRUARY 24, 2015 Session P-T6 Poster Session

879 Growth and Bone Markers in Malawian Infants Pre- and Postnatally Exposed to Tenofovir Giuseppe Liotta 2 ; Marco Floridia 1 ; Mauro Andreotti 1 ; Haswell Jere 3 ; Clementina Galluzzo 1 ; Sandro Mancinelli 2 ; Maria Cristina Marazzi 4 ; StefanoVella 1 ; Marina Giuliano 1 ; Leonardo Palombi 2 1 Istituto Superiore di Sanità, Rome, Italy; 2 University of Tor Vergata, Rome, Italy; 3 Community of S.Egidio, Blantyre, Malawi; 4 Lumsa University, Rome, Italy 880 Lower Insulin, Acylcarnitines, and Branch-Chain Amino Acids in HIV- Exposed Infants Jennifer Jao 1 ; Brian Kirmse 2 ; ChunliYu 3 ; Fanny Epie 4 ; Emmanuel Nshom 4 ; Rhoda Sperling 5 ; Elaine J. Abrams 6 ; Derek LeRoith 7 ; Mitchell Geffner 8 ; Irwin Kurland 9 1 Icahn School of Medicine at Mount Sinai, New York, NY, US; 2 Children’s National Health System, Washington, DC, US; 3 Icahn School of Medicine at Mount Sinai, New York, NY, US; 4 Cameroon Baptist Convention Health Services, Bamenda, Cameroon; 5 Icahn School of Medicine at Mount Sinai, New York, NY, US; 6 ICAP at Columbia University, New York, NY, US; 7 Icahn School of Medicine at Mount Sinai, New York, NY, US; 8 Keck School of Medicine at University of Southern California, Los Angeles, CA, US; 9 Albert Einstein College of Medicine, New York, NY, US 881 No Effect of Maternal HIV and In-Utero cART on Infant Leukocyte Telomere Length Abhinav Ajaykumar 1 ; Hugo Soudeyns 2 ; Fatima Kakkar 2 ; Jason Brophy 3 ; Ari Bitnun 4 ; Ariane Alimenti 1 ; Deborah Money 1 ; Arianne Albert 5 ; Hélène C. Côté 1 On behalf of the CIHRTeam in Cellular Aging and HIV Comorbidities inWomen and Children (CARMA) 1 University of British Columbia, Vancouver, Canada; 2 Université de Montréal, Montreal, Canada; 3 University of Ottawa, Ottawa, Canada; 4 University of Toronto, Toronto, Canada; 5 Women’s Health Research Institute, Vancouver, Canada 882 Long-Term Effects of In Utero ARV Exposure on Cardiac Function in HIV- Exposed Uninfected Youth Vitor C. Guerra 1 ; Erin Leister 2 ; Paige L.Williams 2 ; Steven E. Lipshultz 3 ; RussellVan Dyke 1 ; Rohan Hazra 4 ; Steven D. Colan 5 1 Tulane University, New Orleans, LA, US; 2 Harvard School of Public Health, Center for Biostatistics in AIDS Research, Boston, MA, US; 3 Wayne State University School of Medicine, Detroit, MI, US; 4 Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, US; 5 Boston Children’s Hospital, Harvard Medical School, Boston, MA, US 2:30 pm– 4:00 pm Coinfections Among HIV-Exposed Infants and Children 883 Burden of Malaria in a Birth Cohort of HIV-Exposed Ugandan Infants Abel Kakuru 2 ; Paul Natureeba 2 ; Albert Plenty 1 ; Edwin Charlebois 1 ; Deborah Cohan 1 ;Tamara Clark 1 ; Diane Havlir 1 ; Moses R. Kamya 3 ; Grant Dorsey 1 ; Theodore Ruel 1 1 University of California San Francisco, San Francisco, CA, US; 2 Makerere University-University of California, San Francisco Research Collaboration, Kampala, Uganda; 3 Makerere University College of Health Sciences, Kampala, Uganda 884 CMV Transmission FromHIV-infectedWomen Randomized to Formula Versus Breastfeeding Barbra Richardson 1 ; Grace John-Stewart 1 ;Vincent Emery 2 ; Claire Atkinson 4 ; Ruth Nduati 3 ; Kristjana H. Ásbjörnsdóttir 1 ; Julie M. Overbaugh 5 ; Michael Boeckh 5 ; Jennifer A. Slyker 1 1 University of Washington, Seattle, WA, US; 2 University of Surrey, Guildford, United Kingdom; 3 University of Nairobi, Nairobi, Kenya; 4 University College London, London, United Kingdom; 5 Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, US 885 Is the Prevalence of M. tuberculosis Infection Higher in HIV-Exposed Children? Palwasha Y. Khan 1 ; Katherine L. Fielding 1 ; Dominic Mulawa 2 ; Regina Chiumya 2 ;Themba Mzembe 2 ; Olivier Koole 1 ; Judith R. Glynn 1 ; Amelia C. Crampin 1 1 London School of Hygiene and Tropical Medicine, London, United Kingdom; 2 Karonga Prevention Study, Karonga, Malawi Session P-T5 Poster Session Poster Hall

Poster Hall

2:30 pm– 4:00 pm ART Adherence, Adverse Effects, and Retention Among Pregnant Women and Infants 886 ARV Adherence Associated with Reduced Breastmilk HIV Viral Load and HIV Transmission Nicole L. Davis 4 ; William C. Miller 4 ; Michael G. Hudgens 4 ; Charles S. Chasela 1 ; Dorothy Sichali 2 ; Julie A. Nelson 4 ; Joseph Rigdon 4 ; Sascha R. Ellington 3 ; Athena P. Kourtis 3 ; Charles M. van der Horst 4 BAN study team 1 University of Witswatersand, Johannesburg, South Africa; 2 UNC Project-Malawi, Lilongwe, Malawi; 3 US Centers for Disease Control and Prevention (CDC), Atlantaq, GA, US; 4 University of North Carolina, Chapel Hill, NC, US 887 PeripartumHair Levels of Antiretrovirals Predict Viral Suppression in UgandanWomen Catherine A. Koss 1 ; Peter Bacchetti 1 ; Deborah Cohan 1 ; Paul Natureeba 1 ; Howard Horng 1 ; Tamara Clark 1 ; Edwin Charlebois 1 ; Moses R. Kamya 2 ; Diane Havlir 1 ; Monica Gandhi 1 1 University of California San Francisco, San Francisco, CA, US; 2 Makerere University College of Health Sciences, Kampala, Uganda 888 Side Effects and Treatment Adherence After ART Initiation in Pregnancy in South Africa Tamsin Phillips 1 ; AllisonV. Zerbe 2 ; Agnes Ronan 1 ; Claude A. Mellins 3 ; Robert H. Remien 3 ; James A. McIntyre 4 ; Greg Petro 1 ; Elaine J. Abrams 2 ; Landon Myer 1 1 University of Cape Town, Cape Town, South Africa; 2 ICAP at Columbia University, New York, NY, US; 3 New York State Psychiatric Institute and Columbia University, New York, NY, US; 4 Anova Health Institute, Johannesburg, South Africa 889 Efficacy of Mobile Phone Use on Adherence to Nevirapine Prophylaxis and Retention in Care Among HIV-Exposed Infants Lilian M. Kebaya ; DaltonWamalwa; Nyambura Kariuki; Bashir Admani; RuthW. Nduati University of Nairobi, Nairobi, Kenya 890 HIV Care Continuum for PostpartumWomen in Philadelphia: Barriers and Facilitators JoellaW. Adams 1 ; Kathleen Brady 1 ;Yvonne Michael 3 ; Baligh R.Yehia 4 ; Florence Momplaisir 2 1 Philadelphia Department of Public Health, Philadelphia, PA, US; 2 Drexel University College of Medicine, Philadelphia, PA, US; 3 Drexel University School of Public Health, Philadelphia, PA, US; 4 University of Pennsylvania, Philadelphia, PA, US 2:30 pm– 4:00 pm Pharmacokinetics and Safety of ART During Pregnancy 891 Raltegravir Plasma Concentrations on HIV-1 Infected Pregnant Women Emilie Belissa; Amine Benchikh; Charlotte Charpentier; MorganeValentin; Agnes Bourgeois- Moine; Sylvie Lariven; Florence Damond;YazdanYazdanpanah; Sophie Matheron; Gilles Peytavin APHP, Bichat-Claude Bernard Hospital, Paris, France 892 Etravirine Pharmacokinetics During Pregnancy and Postpartum Brookie M. Best 1 ; Angela Colbers 2 ; JiajiaWang 3 ; GrahamTaylor 4 ; Alice Stek 5 ; Marjo van Kasteren 6 ; Mark Mirochnick 7 ; David Burger 2 On behalf of the IMPAACT P1026s ProtocolTeam and the PANNA Network 1 University of California San Diego, San Diego, CA, US; 2 Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands; 3 Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, MA, US; 4 Imperial College Healthcare NHS Trust, London, United Kingdom; 5 University of Southern California School of Medicine, Los Angeles, CA, US; 6 St. Elisabeth Hospital, Tilburg, Netherlands; 7 Boston University School of Medicine, Boston, MA, US 893 Pharmacokinetics of Etravirine in HIV-1–Infected Pregnant Women M Ramgopal 1 ; O Osiyemi 2 ; C Zorrilla 3 ; HM Crauwels 4 ; R Ryan 5 ; K Brown 6 ;V Hillewaert 7 ; B Baugh 6 1 Midway Immunology and Research Center, Fort Pierce, FL, US; 2 Triple O Research Institute PA, West Palm Beach, FL, US; 3 University of Puerto Rico School of Medicine, San Juan, US; 4 Janssen Infectious Diseases, Beerse, Belgium; 5 Janssen Research & Development, Titusville, NJ, US; 6 Janssen Therapeutics, Titusville, NJ, US; 7 Janssen Research & Development, Beerse, Belgium Session P-T7 Poster Session Poster Hall

Poster Listings

68

CROI 2015